Faeth Therapeutics, Inc. (FTH)
8.50
-0.19
(-2.19%)
USD |
NASDAQ |
Nov 20, 12:22
Faeth Therapeutics Cash from Operations (Quarterly) : -13.00M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -13.00M |
| June 30, 2026 | -15.67M |
| March 31, 2026 | -10.73M |
| December 31, 2025 | -3.864M |
| September 30, 2025 | -3.586M |
| June 30, 2025 | -5.909M |
| March 31, 2025 | -7.094M |
| December 31, 2024 | -5.792M |
| September 30, 2024 | -5.47M |
| June 30, 2024 | -5.792M |
| March 31, 2024 | -7.616M |
| December 31, 2023 | -6.163M |
| September 30, 2023 | -4.661M |
| June 30, 2023 | -9.463M |
| Date | Value |
|---|---|
| March 31, 2023 | -11.74M |
| December 31, 2022 | -9.574M |
| September 30, 2022 | -6.803M |
| June 30, 2022 | -11.90M |
| March 31, 2022 | -10.75M |
| December 31, 2021 | -7.868M |
| September 30, 2021 | -5.577M |
| June 30, 2021 | -6.047M |
| March 31, 2021 | -10.77M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -2.767M |
| March 31, 2020 | -6.46M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | -2.902M |
| Zymeworks, Inc. | -23.34M |
| Rhythm Pharmaceuticals, Inc. | -3.062M |
| Cue Biopharma, Inc. | -10.08M |
| Yarrow Bioscience, Inc. | -89.96M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.175M |
| Cash from Financing (Quarterly) | 0.104M |
| Free Cash Flow | -43.28M |
| Free Cash Flow Per Share (Quarterly) | -0.5033 |
| Free Cash Flow to Equity (Quarterly) | -12.56M |
| Free Cash Flow to Firm (Quarterly) | -13.00M |
| Free Cash Flow Yield | -19.70% |